ARTICLE | Distillery Therapeutics
Cancer
March 22, 2017 2:21 PM UTC
Cell culture and mouse studies suggest the NME2 inhibitor stauprimide could help treat MYC-driven cancer. Stauprimide is known to inhibit NME2-mediated MYC transcription in normal cells. In multiple M...
BCIQ Company Profiles